Accessibility Menu
Hh Biotechnology logo

Hh Biotechnology(OTC) HHBT

Market Cap$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-100%
1 Year+0%
1 Month-50%
$0.00
+0.00%
+0.00Today
Hh Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.002025-11-03
Hh Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-50%USD 0.002025-08-01
1 month-50%USD 0.002025-08-01
3 month-50%USD 0.002025-08-01
Year to date+0%USD 0.002024-09-30
1 year+0%USD 0.002024-09-30
3 year-99.99%USD 1.132022-05-27
5 year-99.92%USD 0.132020-10-05
Since inception-100%USD 3.902005-07-14

Hh Biotechnology Financials at a Glance

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-216.14 (Low)

Price

$0.00

Volume

8,355

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

HHBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hh Biotechnology

HH Biotechnology Holdings Company operates within the health and green industries, focusing on the cultivation and distribution of macadamia nuts. These nuts are utilized in a wide range of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations.

Products and Services
  • Macadamia nuts for culinary and wellness applications
  • Personal care and cosmetic products derived from macadamia
  • Distribution services for health-focused products
Growth Outlook
  • Established in 1987, the company has a long-standing market presence
  • Increasing demand for health and wellness products supports growth potential
  • Expansion into new markets is anticipated to drive revenue growth
Financial Highlights
  • Market capitalization stands at approximately $1,406
  • Current ratio of 2.32 indicates strong liquidity
  • Net profit margin of 30.99% reflects operational efficiency
HH Biotechnology Holdings Company has positioned itself as a key player in the health and green industries, leveraging the growing consumer interest in wellness and sustainability. The company’s focus on macadamia nuts not only caters to culinary needs but also taps into the expanding market for personal care and cosmetic products. With a solid foundation established over decades, the company is well-placed to capitalize on emerging trends in health and wellness. The growth outlook is promising, supported by increasing consumer demand for health-oriented products and potential market expansion. Financially, the company demonstrates strong liquidity and operational efficiency, as evidenced by its current ratio and net profit margin. These factors contribute to a compelling narrative for potential investors interested in the health and green sectors.
AI Generated • Jul 26, 2026

Industry

Real Estate Management and Development

Headquarters

Shenyang, LI 110003, CN

HHBT Financials

Key Financial Metrics (TTM)

Gross Margin

29.45%

Operating Margin

38.78%

Net Income Margin

30.99%

Return on Equity

8.78%

Return on Capital

9.43%

Return on Assets

5.33%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

14.06M

Volume

8.36K

Avg. Volume

0

Financials (TTM)

Gross Profit

$2.35M

Operating Income

$3.10M

EBITDA

$5.44M

Operating Cash Flow

$3.57M

Capital Expenditure

-$41.90K

Free Cash Flow

$3.53M

Cash & ST Invst.

$9.82M

Total Debt

$4.63M

Hh Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACANAmeriCann, Inc.
$0.00+0.00%
XXFPLFFP Partners, L.P.
$0.00-0.00%
CRXPFVert Infrastructure Ltd.
$0.00+0.00%
COWPPCanal Capital Corporation PFD EXCH $1.30
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About HHBT

What is the current price of Hh Biotechnology?

Hh Biotechnology is trading at $0.00 per share.

What is the 52-week range for Hh Biotechnology?

Over the past 52 weeks, Hh Biotechnology has traded between $0.00 and $0.00.

How much debt does Hh Biotechnology have?

Hh Biotechnology total debt is unavailable.

How much cash does Hh Biotechnology have on hand?

Hh Biotechnology does not have cash on hand data available.

What is Hh Biotechnology’s dividend yield?

Hh Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.